Tag: rosuvastatin
-
Pharmac Expands Rosuvastatin Access for All New Zealanders
Pharmac will widen access to Rosuvastatin from October 1, 2026, removing all eligibility criteria, including ethnicity. This move aims to improve health outcomes and reduce hospital admissions for high cholesterol patients.
HealthPolitics and GovernmentMedical ScienceGeneral PoliticsEconomySocial Issues RosuvastatinPharmaccholesterolheart diseaseDavid Seymourmedicine accessNew Zealand Government